Retatrutide
Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. It is one of the most studied compounds in metabolic and body-composition research. Available in 5 mg and 10 mg vials to suit different study scales.
Research Applications
- Metabolic pathway modulation studies
- Body-composition and energy-expenditure research
- Receptor-binding and selectivity assays
- Dose-response curve investigations
- Multi-week in-vivo research designs
Handling & Storage
- Lyophilised powder — store at -20 °C before reconstitution
- Reconstitute with bacteriostatic water; inject slowly along the vial wall
- Reconstituted solution: store at 2–8 °C, use within 30 days
- Protect from light; avoid repeated freeze-thaw cycles
